Dec'05 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | ($92.5M) | ($219.6M) | $191.3M | $153.0M | $333.5M | $260.1M | $233.6M | $251.8M | $253.8M | $257.0M | $328.3M | $402.6M | $412.2M | $491.9M | $231.2M | $296.5M | $164.6M | $121.7M | $267.7M | ($645.6M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Encompass Health Corporation's last 12-month Free Cash Flow is $280.2M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Encompass Health Corporation's Free Cash Flow growth was 4.7%. The average annual Free Cash Flow growth rates for Encompass Health Corporation have been (11.7%) over the past three years, 3.9% over the past five years.
Over the last year, Encompass Health Corporation's Free Cash Flow growth was 4.7%, which is higher than industry growth of 1.8%. It indicates that Encompass Health Corporation's Free Cash Flow growth is Good.